Antiretroviral Pharmacovigilance Training Course Dar es Salaam, United Republic of Tanzania 23 rd – 28 th November 2009.

Slides:



Advertisements
Similar presentations
HIV Situation in India Dr Sunil Gaikwad.
Advertisements

HIV/AIDS Estimation and Projections: Overview of Methods and Activities.
Harmonization of donor reporting requirements for antiretrovirals and related drugs Presented at the WHO meeting, Geneva ( October 2005) Oteba Olowo.
"3 by 5" progress December 2005 Progress on global access to HIV antiretroviral therapy | 12 April |2 | Antiretroviral therapy coverage in low-
Sevene E, Mariano A, Mola D Faculty of Medicine / Ministry of Health Pretoria, September 2004 PHARMACOVIGILANCE SYSTEM - MOZAMBIQUE INTRODUCING PV INTO.
EMTCT Tanzania Experience 6 th Joint Biennial HIV & AIDS Sector Review Dr MD Kajoka PMTCT Coordinator.
ART: The Basics William Aldis World Health Organization Bangkok, September 14, 2005.
MONITORING SYSTEM FOR THE ANTIRETROVIRAL THERAPY IN BRAZIL: LESSONS LEARNED AND FUTURE DIRECTIONS Marco Vitória, MD Brazilian STD/AIDS Programme - MOH.
Treatment challenges of 2 nd /3 rd line HIV/AIDS, hepatitis-C in Seychelles BY DR LOUINE MOREL.
Prevention of Mother-to-Child Transmission of HIV in Ghana
Office of Global Health and HIV (OGHH) Office of Overseas Programming & Training Support (OPATS) Maternal and Newborn Health Training Package Session 11:
The Global Response to AIDS: Does It Pass the Test for Women? Peter Piot Institute for Global Health Imperial College.
“Getting to Zero: Thailand’s Experience with E-MTCT” Petchsri Sirinirund Advisor on HIV/AIDS Policy and Programme Department of Disease Control, Thailand.
2,100,000 Number of pregnant women with HIV/AIDS 200,000Number of pregnant women receiving PMTCT 630,000Number of MTCT new infections 2,000,000Number of.
Possible solution: Change testing & care for patients in TB treatment Old system TB patient treated at TB center Referred to VCT center for HIV testing.
A generation of children free from AIDS is not impossible Children and AIDS Fourth Stocktaking Report, 2009.
PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV WHAT’S NEW Prepared by Dr. Debbie Carrington National HIV/AIDS Prevention & Control Programme Ministry.
HIV/AIDS: A Global and Regional Perspective AIDS in Post 2015 Development Agenda.
Training course on Introducing pharmacovigilance into HIV/AIDS programmes Pretoria, South Africa, September 1-10,2004.
Pharmacovigilance in Kenya Dr. Dorine Kagai (NASCOP) Mr. George Muthuri (PPB) Ministry of Medical Services 23 nd November, 2009 ARV PV TRAINING TZ.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides Thailand.
PHARMACOVIGILANCE AND CLINICAL TRIALS DIVISION 20 August 2015 Victoria Falls Protecting Your Right to Quality Medicines and Medical Devices.
Our vision: Healthier communities, Excellence in healthcare Our values: Teamwork, Honesty, Respect, Ethical, Excellence, Caring, Commitment, Courage DOTS.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
HIV/AIDS IN PERU. Map General statistics Population million Life expectancy: Male: years Female: 75.6 years GNI billion Literacy.
Bi-national Commission for Collaboration on Health Guyana and Suriname. Presenter Mr. Nicholas Persaud –National HIV Care and Treatment Coordinator. Guyana.
00002-E-1 – 1 December 2002 The AIDS Pandemic: an Update on the Numbers and Needs l What are the numbers for 2002? l What are the global and regional trends?
EARLY CHILDHOOD OUTCOMES AT THE BOTSWANA- BAYLOR CHILDREN’S CLINICAL CENTRE OF EXCELLENCE: A REPORT TO THE WHO TECHNICAL REFERENCE GROUP ON PEDIATRIC CARE.
‘Gaps in the global HIV/AIDS success story Copenhagen December 2 nd 2013 Gaps in the global HIV/AIDS success story Briefing on HIV/AIDS in Europe Martin.
Training course on the Pharmacovigilance of antiretroviral medicines 23 – 28 November 2009 Rationale, Objectives and Expected Outcomes.
SCALING UP ART IN KENYA: Programmatic issues Mary Wangai MD Deputy Director National AIDS and STD Programme.
Prevention of Mother to Child Transmission Antiretroviral Drugs to Prevent MTCT.
What pharmacovigilance can do for you! relationship assessment is a better concept 24 Nov Dar es Salaam.
Dr Ihor Perehinets MD, MPH National Technical Officer WHO CO in Ukraine Pharmacovigilance (PV) in HIV treatment in Ukraine: Situation Analysis Dar es Salaam.
WORLD AIDS DAY Zero new HIV infections Zero discrimination Zero AIDS-related deaths.
Training Course for Introducing Pharmacovigilance of HIV Medicines: November at the White Sands Hotel, Dar es Salaam, Tanzania. TANZANIA PHARMACOVIGILANCE.
Challenges for the WHO Programme for International Drug Monitoring Mary Couper, Shanthi Pal, Mitsuko Imai, Maria Cuadrillero, Ana Garcia.
Pharmacovigilance in HIV/AIDS Public Health Programmes: Luxury or Priority? November 2009, dar Es Salaam.
Antiretroviral treatment programme in Thyolo district, Malawi Southern Region. MSF Luxembourg & Thyolo District Health Services - Strategic information.
AN OVERVIEW OF PHARMACOVIGILANCE OF HIV/AIDS IN NIGERIA
PHARMACOVIGILANCE PLAN FOR TANZANIA PREPARED BY EMMA & MARY 10 TH SEPTEMBER 2004.
1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 06/06 e Global HIV epidemic, 1990 ‒ 2005*HIV epidemic in sub-Saharan Africa, 1985 ‒ 2005* Number of people living with HIV % HIV prevalence, adult (15-49)
Africans and HIV in the UK: an epidemiological perspective May 2006 Valerie Delpech On behalf of the HIV Reporting Section with special thanks to Julia.
Global HIV Epidemiology Carey Farquhar, MD, MPH Grace John-Stewart MD, PhD Departments of Medicine, Epidemiology and Global Health.
"Where did the money go? Findings from the National AIDS Spending Assessment Report.“ Authors: Annang Dennis 1, Asante Felix 2, Yeboah Kenneth 3, Epeh.
United Republic of Tanzania Ministry of Health & Social Welfare MINISTRY OF HEALTH AND SOCIAL WELFARE NATIONAL AIDS CONTROL PROGRAM HIV CARE AND TREATMENT.
INVESTING IN COMMUNITY SYSTEMS TO SUPPORT LIFELONG ART INITIATED IN MATERNAL & CHILD HEALTH SETTINGS Dr. Chewe Luo MD, PhD, FRCP UNICEF PROGRAM DIVISION.
Prevention of Mother-to-Child Transmission of HIV: Scale-up of Critical Services in Uganda (District- based Approach) Edward Bitarakwate, MD, MPH Technical.
2008 International AIDS Conference UNGASS reporting Matthew Warner-Smith Monitoring and Evaluation Division UNAIDS 2008 International AIDS Conference Satellite.
1 Module 1: [Basic] Unit 1: [HIV Epidemics and Key Populations] Lesson 2: [Levels of HIV Epidemic in the World] “Community-Based HIV Surveillance” Online.
1 06/06 e Global HIV epidemic, 1990 ‒ 2005*HIV epidemic in sub-Saharan Africa, 1985 ‒ 2005* Number of people living with HIV % HIV prevalence, adult (15-49)
OB/GYN Review Course: Women and HIV Questions Peter G. Gulick, DO, FACP, FACOI Associate Professor.
Outcome of a Prevention of mother to child transmission (PMTCT ) programme following Implementation of prophylaxis for HIV infected pregnant women in Barbados:
Pharmacovigilance respect to ARV th 2009 White sand Hotel, Dar es salaam.
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
The Incidence of AIDS-related Diseases and HIV-Infection Control in the Republic of Komi V.M. Chzhao State Establishment “The Republican Centre for.
Northern Dimension HIV/AIDS Group meeting Tallin, April 2008
TB- HIV Collaborative activities in Romania- may 2006 status
THE HEALTH SECTOR RESPONSE TO THE HIV/AIDS EPIDEMIC
World Health Organization
Cross-sectional assessment of patient outcomes using a systematic file review process: Results from 12,987 patient files Ambereen Jaffer, Gesine Meyer-Rath,
Madisa Mine National Health Laboratory Gaborone, BOTSWANA
Improving Access to Treatment of PLHIV, the Role of the National Health Insurance Scheme
Pharmacovigilance in Uganda
"3 by 5" progress December 2005.
China 2010 UNGASS Country Progress Report
Papua New Guinea.
Monitoring of Antiretroviral therapy (ART)delivery by Regional Tuberculosis Officers (RTO) in Malawi: Rhehab Chimzizi Anthony Harries Edwin Libamba Maxwell.
Collaborative TB/HIV activities in European Region
Presentation transcript:

Antiretroviral Pharmacovigilance Training Course Dar es Salaam, United Republic of Tanzania 23 rd – 28 th November 2009

NATIONAL AIDS/STI CONTROL PROGRAMME FOOD AND DRUGS BOARD SAFETY MONITORING OF ARVs IN GHANA

5/31/20163 Agenda Ghana, Background Information HIV Situation in Ghana ARV therapy General Pharmacovigilance activities – Training of health professionals Pharmacovigilance in Public Health Programmes

HIV prevalence is consistently over 1% among pregnant women Although sub-populations at high risk may continue to contribute disproportionately to the spread of HIV, sexual networking in the general population is sufficient to sustain an epidemic independent of sub- populations at higher risk for infection. The HIV Situation in Ghana: Ghana Has a Generalized Epidemic

First case of AIDS in Ghana was in 1986 The median HIV prevalence (ANC) – % – % – % – % – % – % – %

National Estimates In 2008, the estimated adult national HIV prevalence is 1.7%, Estimated 236,151 persons Living with HIV and AIDS – Males- 98,306 – Females- 137,841 New HIV infections: – Adults- 18,564 – Children- 3,978 AIDS deaths- 18,082 (2,241 Children)

Indicator2008 HIV Adults + Children 236,151 HIV population- Children 20,808 Prevalence Adult (%) 1.7 Incidence (%)0.13 New HIV infections- Adult 18,564 New HIV Infections- Children 3,978 Annual AIDS deaths 15,841 Annual AIDS deaths- Children 2,241 Need for ART- Adult (15+) 63,137 Need for ART- Children 6,086 Mothers needing PMTCT 13,095

HIV Prevalence By Region Northern Upper West Volta Upper East Central Brong Ahafo Western Greater Accra Ashanti Eastern Region Prevalence

ART Services Data Indicator Target as at June 2009 Results as at June Number of people with advanced HIV infection receiving ARV combination therapy 37,50029,010 2 Number of service delivery points providing ARV combination therapy 59125

Cumulative # initiated on ART # of Deaths # who Stopped treatment # Lost to Follow up # Currently on ART Adults 27,6441, ,37424,847 Pediatrics 1, ,260 Total 29,0101, ,39326,107 (90%) ART Services Data

ARV Drug Regimen 1 st Line 2 nd Line Alternative 2 nd Line

First line regimen First choice drugs First Option – Zidovudine 300mg 12hrly + Lamivudine 150mg 12hrly + Nevirapine 200mg daily for 14 days, then 12hrly Second Option Zidovudine 300mg 12hrly + Lamivudine 150mg 12hrly + Efavirenz 600mg nocte 5/31/201612

First line regimen Second Choice drugs First Option – Stavudine 30mg 12hrly + Lamivudine 150mg 12hrly + Nevirapine 200mg daily for 14 days, then 12hrly Second Option – Stavudine 30mg 12hrly + Lamivudine 150mg 12hrly + Efavirenz 600mg nocte 5/31/201613

Second line regimen First Alternative Abacavir + Tenofovir + Nelfinavir » or Abacavir + Tenofovir + Lopinavir/r Second Alternative Didanosine + Abacavir + Nelfinavir » or Didanosine + Abacavir + Lopinavir/r 5/31/201614

5/31/ ADR Reports Spontaneous Reporting YearNo. of ReportsARTPercentage % % % Jan-Sept % Total %

Nature of ADRs DescriptionTotal Number in Database Skin rashes15 dizziness/drowsiness5 Vomiting4 Weakness4 Insomnia4 Nightmares4 Drop in haemoglobin3 Others (diarhoea, oedema, abdominal pains, bloody stools, etc)

ADR Reporting VigiFlow since 2007 Two members of staff of FDB involved Reports sent after causality assessment 120 (90.91%) reports committed to VigiFlow since Jan (90.91%) reports committed to vigiflow in 2009 alone. Search and statistics not fully untilized 5/31/201617

ADR Reporting YearNo. of Reports Received No. Committed to vigiflow Percentage Total /31/201618

5/31/ PV in Public Health Programmes Cohort Event Monitoring of Antimalarials sponsored by the NMCP Sensitization for Yaws and TB control Programmes Pharmacovigilance presentation to managers of all PHPs during annual review meeting Cohort Event Monitoring at four ART sites (by CTCPT, UGMS) – Police Hospital (Greater Accra Region) – St. Martins de Porres Hospital (Eastern Region) – Koforidua Regional Hospital (Eastern Region) – Atuah Government Hospital (Eastern Region)

5/31/ Publication of a handbook on management of Adverse Drug Reactions to ARVs (CTCPT) Number of healthcare professionals trained in pharmacovigilance since meeting in Geneva in April 2008 –2008:-301 –2009:-433 National ART training for the over 130 sites place emphasis on ADR Training

5/31/ Challenges Underreporting Lack of Institutional collaboration and commitment Inadequate resources – Human – Financial – Logistics

5/31/ Way Forward Sensitization and training of ART medical teams on PV Incorporation of Pv reporting into existing ART reporting requirements – Data officers to be trained to support clinical staff in this regard Effective institutional collaboration Harmonization of reporting forms Leadership commitment and advocacy Proposal to review AEFI Reporting Form

5/31/ Thank you THANK YOU